Redline Power Rush by VPX — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

0.625 fl. Oz. Serving Size

2 Servings

Other Combinations Product Type

0% Evidence Coverage

Supplement Facts — Evidence Check

Calories

Total Carbohydrates

Total Fat

Vitamin C

(100% DV)

Niacinamide

(25% DV)

Vitamin B12

(2083% DV)

Vitamin B6

(37.5% DV)

Folic Acid

(50% DV)

Proprietary Blend

Other Ingredients

highly purified Water Malic Acid Phosphoric Acid natural Red color Sucralose Potassium Sorbate Glycerin Disodium EDTA Sodium Benzoate Natural and Artificial flavors and Defoaming Agent

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

RECOMMENDED USE: Shake well prior to use. Always begin use with one-quarter bottle (0.63 fl.oz. [about three capfuls]) of REDLINE(R) POWER RUSH daily to assess tolerance. Never exceed more than one half (1/2) bottle per 7 hours or one full bottle daily. One half (1/2) bottle is one full serving.

⚠️ Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

Caution: Do not use this product if you are pregnant or nursing or have a medical condition. This product contains caffeine and should not be used with any other caffeine containing products. This product is intended for use by healthy individuals only.

Phenylketonurics: Contains Phenylalanine.

Not for use by individuals under the age of 18.

🧪 Formulation Notes

Contains no fruit juice.

Additional Information

*Individual results may vary.

Refers to consuming entire two ounce bottle.

Product Details

UPC / SKU 6 10764 37032 7

DSLD Entry Date 2011-11-25

Product Type Other Combinations

Form Liquid

Brand VPX

DSLD ID 2021

Data Updated 2026-04-11

Research Evidence

241 Research Sources

55 Avg Quality Score

113 Meta Analysis

75 Systematic Review

32 Rct

11 Clinical Trial

3 Other

3 Regulatory Source

1 Cochrane Review

1 Narrative Review

1 Openfda Safety

A Niacin for primary and secondary prevention of cardiovascular events

Meta Analysis The Cochrane database of systematic reviews 2017

PubMed DOI Cochrane

A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases

Meta Analysis BMJ (Clinical research ed.) 2013

PubMed DOI

A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients

Meta Analysis BMJ (Clinical research ed.) 2014

PubMed DOI

A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk

Meta Analysis Nature medicine 2024

PubMed DOI

A Meta-analysis and imputation refines the association of 15q25 with smoking quantity

Meta Analysis Nature genetics 2010

PubMed DOI

A Genome-wide meta-analyses identify multiple loci associated with smoking behavior

Meta Analysis Nature genetics 2010

PubMed DOI

A Antidepressants for smoking cessation

Meta Analysis The Cochrane database of systematic reviews 2014

PubMed DOI

A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne

Meta Analysis The Cochrane database of systematic reviews 2020

PubMed DOI Cochrane

B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis

Meta Analysis JAMA network open 2019

PubMed DOI

B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis

Meta Analysis JAMA 2016

PubMed DOI

View all evidence for Niacin →